196 related articles for article (PubMed ID: 15850989)
1. Dual inhibition of cyclo-oxygenases and 5-lipoxygenase: a novel therapeutic approach to inflammation?
Naveau B
Joint Bone Spine; 2005 May; 72(3):199-201. PubMed ID: 15850989
[No Abstract] [Full Text] [Related]
2. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
Celotti F; Durand T
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
[TBL] [Abstract][Full Text] [Related]
3. Anti arthritic drugs--SMi conference: dual inhibitors. 28-29 April 2003, London, UK.
Evans R
IDrugs; 2003 Jun; 6(6):552-4. PubMed ID: 12861983
[No Abstract] [Full Text] [Related]
4. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs.
Charlier C; Michaux C
Eur J Med Chem; 2003; 38(7-8):645-59. PubMed ID: 12932896
[TBL] [Abstract][Full Text] [Related]
6. A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase.
Rioja I; Terencio MC; Ubeda A; Molina P; Tárraga A; Gonzalez-Tejero A; Alcaraz MJ
Eur J Pharmacol; 2002 Jan; 434(3):177-85. PubMed ID: 11779581
[TBL] [Abstract][Full Text] [Related]
7. Is licofelone, a dual inhibitor of cyclo-oxygenase and 5-lipoxygenase, a promising alternative in anti-inflammatory therapy?
Bannwarth B
Fundam Clin Pharmacol; 2004 Feb; 18(1):125-30. PubMed ID: 14748764
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase enzymes in allergic inflammation and asthma.
Carey MA; Germolec DR; Langenbach R; Zeldin DC
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):157-62. PubMed ID: 12895598
[TBL] [Abstract][Full Text] [Related]
9. Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer?
Gambaro G
Nephrol Dial Transplant; 2002 Jul; 17(7):1159-62. PubMed ID: 12105234
[No Abstract] [Full Text] [Related]
10. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
Fiorucci S; Meli R; Bucci M; Cirino G
Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
[TBL] [Abstract][Full Text] [Related]
11. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
12. Is there a COX-fight during inflammation?
Parnham MJ
Inflamm Res; 1998 Feb; 47(2):43. PubMed ID: 9535539
[No Abstract] [Full Text] [Related]
13. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts.
Stockton RA; Jacobson BS
Mol Biol Cell; 2001 Jul; 12(7):1937-56. PubMed ID: 11451994
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenases, structure, biological functions and the role in inflammation processes].
Kotyla PJ; Sliwińska-Kotyla B; Kucharz EJ
Pol Arch Med Wewn; 2001 Oct; 106(4):963-6. PubMed ID: 11993417
[No Abstract] [Full Text] [Related]
16. Cyclooxygenase, lipoxygenase and tumor angiogenesis.
Nie D; Honn KV
Cell Mol Life Sci; 2002 May; 59(5):799-807. PubMed ID: 12088280
[TBL] [Abstract][Full Text] [Related]
17. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
He W; Liu CF; Huang CQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
[TBL] [Abstract][Full Text] [Related]
18. [Safe use of anti-inflammatory analgesics].
Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
[No Abstract] [Full Text] [Related]
19. COX-2 inhibitors for colorectal cancer.
Elder DJ; Paraskeva C
Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
[No Abstract] [Full Text] [Related]
20. Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate.
Juránek I; Suzuki H; Yamamoto S
Biochim Biophys Acta; 1999 Jan; 1436(3):509-18. PubMed ID: 9989280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
